Histopathological Diagnosis of Malignant Melanoma at the Dawn of 2023: Knowledge Gained and New Challenges
- PMID: 36810571
- PMCID: PMC9944108
- DOI: 10.3390/dermatopathology10010013
Histopathological Diagnosis of Malignant Melanoma at the Dawn of 2023: Knowledge Gained and New Challenges
Abstract
Year after year, the incidence and prevalence rates of cutaneous Malignant Melanoma (MM) show a continuous increase and, according to the most up-to-date American Cancer Society (ACS) projections, it is estimated that 97,610 new melanomas will be diagnosed in 2023 (about 58,120 in men and 39,490 in women) and approximately 7990 people are expected to die of melanoma (about 5420 men and 2570 women) [...].
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Key Statistics for Melanoma Skin Cancer. [(accessed on 25 January 2023)]. Available online: https://www.cancer.org/cancer/melanoma-skin-cancer/about/key-statistics.....
-
- Cazzato G., Colagrande A., Cimmino A., Demarco A., Lospalluti L., Arezzo F., Resta L., Ingravallo G. The Great Mime: Three Cases of Melanoma with Carcinoid-Like and Paraganglioma-Like Pattern with Emphasis on Differential Diagnosis. Dermatopathology. 2021;8:130–134. doi: 10.3390/dermatopathology8020019. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
